Correlation Between Immix Biopharma and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Blueprint Medicines Corp, you can compare the effects of market volatilities on Immix Biopharma and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Blueprint Medicines.
Diversification Opportunities for Immix Biopharma and Blueprint Medicines
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Immix and Blueprint is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Immix Biopharma and Blueprint Medicines
Given the investment horizon of 90 days Immix Biopharma is expected to generate 2.3 times more return on investment than Blueprint Medicines. However, Immix Biopharma is 2.3 times more volatile than Blueprint Medicines Corp. It trades about 0.23 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.18 per unit of risk. If you would invest 160.00 in Immix Biopharma on September 1, 2024 and sell it today you would earn a total of 51.00 from holding Immix Biopharma or generate 31.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Immix Biopharma |
| Blueprint Medicines Corp |
Immix Biopharma and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Blueprint Medicines
The main advantage of trading using opposite Immix Biopharma and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stocks Directory Find actively traded stocks across global markets |